SAR442168 (tolebrutinib) is an orally bioavailable, brain-penetrant, selective, small-molecule inhibitor of Bruton's tyrosine ...

China: A recent case study published in The Open Dentistry Journal sheds light on a dental issue faced by patients with ...

New Delhi: The pharmaceutical major Cipla has got the go-ahead from the Subject Expert Committee (SEC) functional under the ...

A recent study by Yuya Ogino and colleagues created a scoring model for early Crohn's disease (CD) diagnosis based on results ...

Mumbai: Venus Remedies Limited, a pharmaceutical company specializing in critical care injectables, has announced that its ...

Myopia, or nearsightedness, affects two billion people worldwide. Uncorrected myopia can impair vision, disrupting education, ...

USA: A recent study on suspected sepsis in the emergency department (ED) highlighted the overuse of antibiotics. Among 600 ...

A new study published in the journal of Diabetes Research and Clinical Practice showed that following bariatric surgery, ...

Semaglutide promising alternative treatment for chronic myopathy of hyperkalemic periodic paralysis suggests a case report ...

USA: Researchers have found in a new study that betamethasone retreatment restores benefits for severe intraventricular ...

Amid the ongoing controversy on the double shift format for the National Eligibility-Entrance Test for Postgraduate (NEET-PG) ...

Certain common genetic changes might make some people with focal epilepsy less responsive to seizure medications, finds a new ...